Anbio Biotechnology Cash Flow Statement

Cash Flow Statement Dec2022 Dec2023 Dec2024
Operating Activities
Net Income 10.01M2.25M2.37M
Gains from Investment Securities 0.04M0.16M0.34M
Cash from Operations 4.45M0.90M2.08M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.01M0.01M
Change in Working Capital
Change in Receivables -0.72M1.88M-0.82M
Change in Inventory 0.35M-0.35M
Change in Account Payables -0.48M-0.58M0.80M
Change in Accured Expenses -0.49M0.16M-0.06M
Other Working Capital Changes 4.82M-1.05M1.91M
Investing Activities
Change in Acquisitions & Divestments 14.56M20.27M35.80M
Cash from Investing Activities -1.53M1.73M0.34M
Financing Activities
Other financing activities 0.04M0.34M
Cash from Financing Activities -0.04M-0.34M
Additional items
Change in Cash 2.92M2.59M2.07M
Beginning Cash Balance -2.92M7.10M9.69M
Free Cash Flow 4.45M0.90M2.08M
Net Cash Flow 2.92M2.59M2.07M